PLK1 and prostate cancer: The positive control siRNAs targeting known key regulators of the mitotic progression as well as prostate cancer cell proliferation, KIF11 and PLK1 [31], [32], were able to significantly decrease cell viability (Figure 2A) confirming thus transfection efficiency.